Glenmark Pharmaceuticals reports 21% rise in Q3 consolidated net profit

13 Feb 2023 Evaluate

Glenmark Pharmaceuticals has reported results for third quarter ended December 31, 2022 (Q3FY23).

The company has reported fall of 21.52% in its net profit at Rs 430.50 crore for Q3FY23 as compared to Rs 548.52 crore for the same quarter in the previous year. However, total income of the company marginally increased by 0.06% at Rs 2251.20 crore for the quarter under review as compared Rs 2249.80 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported rise of 21.28% in its net profit at Rs 290.76 crore for Q3FY23 as compared to Rs 239.75 crore for the same quarter in the previous year. Total income of the company increased by 11.07% to Rs 3540.27 crore for the quarter under review as compared to Rs 3187.31 crore for the same quarter in the previous year.

Glenmark Pharma Share Price

2000.60 -10.90 (-0.54%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×